Browse drugs

…Introduction The extensive use of asbestos in naval vessels, aircraft, and other UK military infrastructur…

…ression from baseline to 0.8 (n=4; p < 0.05). Dynasore, but not Pitstop, significantly reduced EV uptake which leads to the inhibition …

…iated with remission at 1 year in a real-world asthma cohort on benralizumab.Methods BenRex is a multicentre study of exacerbations on benra…

… benralizumab, 27.3% to 36.4% for dupilumab, 24.2% to 40.9% for mepolizumab, and 11.1% to 33.3% for omalizumab from Year 1 to Year 3. Basel…

…or assessing respiratory symptoms, but ILD is often overlooked. ArtiQ.Spiro, an AI-based support tool for spirometry interpretation, shows …

…olled patients (≥18 years) with severe asthma, newly prescribed mepolizumab (100-mg subcutaneously). Changes from baseline in asthma contro…

…ophilic phenotype. These patients are most likely to respond to inhaled corticosteroids. Recent evidence supports a role for anti-eosinophilic biologic…

…vention arm.Conclusion Although hypertonic saline compared with carbocisteine treatment led to no significant difference in the CAT questionn…

…ng concerns over antimicrobial resistance. The GREAT-2 trial of gremubamab, a bispecific monoclonal antibody targeting PA Psl and PcrV, de…

…Granulocyte colony-stimulating factor (G-CSF) is used alongside cytotoxic chemotherapy regimens to reduce th…

…ncer (NSCLC) ( NCT02818920) evaluated the potential efficacy of pembrolizumab administration in the absence of chemotherapy. This communicati…

…comes in patients receiving immune checkpoint inhibitors. Since acetaminophen is a widely used and essential medication for many patients wit…